Matthew Hein, U.S. Department of Commerce

Should I Pursue Emerging Medtech Markets?

By MedTech Intelligence Staff
Matthew Hein, U.S. Department of Commerce

Many companies go for product approval in smaller markets first. Is that the right decision?

Global healthcare spending is roughly $7 trillion, according to Matthew Hein, International Trade Specialist for the U.S. Department of Commerce. Considering the market outside of the United States is about 25% larger, companies may have more success pursuing product approval in emerging markets—beyond China, India and Brazil—because the technologies may be more helpful for those patient populations and the regulatory burdens more manageable, suggests Hein in the following video, which was filmed during the MedTech Intelligence Global Regulatory conference last week.

 

 

Related Articles

  • Sanobar Syed
    Market Forecasting: Solving the Problems of Too Little or Too Much Data

    Market research and forecasting help ensure that you are investing in a device or drug that is needed and will be well received. In this article, Sanobar Syed, Associate Director of Forecasting, Market Insights and Strategies, BeiGene, highlights strategies to…

  • Amanda Bloom
    MedTech Marketing Pearls for FDA Clearance and Beyond

    As VP of Product Marketing for a MedTech startup, my role is to champion pioneering medical technology, strategically spark interest and drive it out of the design lab and into the field where it will ultimately change, or even save…

  • Veeva Logo
    Veeva Introduces MedTech-Specific Vault CRM

    Veeva Vault CRM for Medtech is a unified customer relationship management (CRM) and content management application built for medtech sales teams, key account managers and medical affairs professionals.

  • FFRangio System
    Medtronic To Acquire CathWorks

    Medtronic will invest up to $75 million and immediately begin co-promotion of CathWorks’ FFRangio System for the noninvasive diagnosis of CAD in the U.S., Europe and Japan, where it is commercially available.

About The Author

MedTech Intelligence